Akari Therapeutics posts updated investor presentation; details not disclosed

Akari Therapeutics Plc

Company furnished an updated corporate presentation as Exhibit 99.1 on Form 8-K.
Presentation will be used in meetings but no specific financial or strategic updates provided.
No new material information available beyond the filing itself.

item 7.01 item 9.01

Akari Therapeutics Plc filing history →

Source: SEC EDGAR

accession 0001641172-25-024732

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.